Chromatics Color Sciences International. Inc; CCSI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI

CCSI 24.69

+0.7%

1:08 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JanyBlueEyes who wrote (4454)	8/19/1998 5:12:00 PM
From: Robin	Read Replies (2) of 5736

Point well taken, Jany, I learned something here! Thank you! I am not a medical expert by far; my expertise is more in the technical arena. My assumption was that the presence of a significant amount of UV light would corrupt the measurement. I did not consider instead the effects of UV exposure on the skin. I assumed that if skin effects occur as you state, that one would simply utilize partial UV immersion (i.e., place the UV blanket over a large, but not complete portion of the body) and use an unexposed area to monitor bilirubin levels. My next question then. Wouldn't it be possible to place the UV blanket over the majority of the baby's body, say from the neck down and leave the head unexposed for monitoring? (As I'm sure you know, the UV blankets are very good at selectively directing light.) What adverse effects would this cause? I can't see any other than a need to increase the exposure time of UV over the remainder of the body to make up for full vs. partial immersion. Rockin' Robin

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next